News - Clinical Investigator
Report available for public review and comment SILVER SPRING, Md., July 25, 2011 /PRNewswire-USNewswire/ -- A U.S.
SAN DIEGO, March 2 /PRNewswire-FirstCall/ -- Orexigen® Therapeutics, Inc. (Nasdaq: OREX), a biopharmaceutical company focused on the treatment of obesity, today announced the appointment of Peter K. Honig, MD, MPH to its board of directors. Dr.
Conference Features Renowned Translational Cancer Researchers and Updates on Key Discoveries, Plus Panel Discussion with Academic and Industry Leaders NEW YORK, April 23 /PRNewswire-USNewswire/ -- Internationally renowned physician-scientists will discuss the rapidly changing cancer research landscape in the US, plus important recent discoveries in translational cancer research, during the first Damon Runyon Cancer Research Foundation Clinical Investigator Symposium.